Codexis, Inc.
CDXS
Rank in Stocks
#18829
Codexis, Inc. is a biotechnology firm dedicated to the discovery, development,... Codexis, Inc. is a biotechnology firm dedicated to the discovery, development, and commercialization of enzymes and other protein-based solutions. Its diverse portfolio encompasses advanced biocatalyst products and related services, specialized chemical intermediates vital for subsequent processing steps, and proprietary biocatalyst panels and kits that empower clients to conduct effective chemistry screening. The company also extends its expertise through biocatalyst screening and sophisticated protein engineering services. Central to its operations is the proprietary CodeEvolver protein engineering technology platform. This innovative platform is instrumental in crafting and delivering high-performance biocatalysts capable of driving chemical transformations, thereby significantly enhancing the efficiency and productivity of manufacturing processes. Beyond industrial applications, the CodeEvolver platform is also leveraged for identifying novel biotherapeutic drug candidates for targeted human diseases, as well as for developing enzymes essential for molecular biology research and in vitro diagnostic applications. Primarily serving pharmaceutical manufacturers, Codexis distributes its products through its dedicated direct sales and business development teams across the United States and Europe. Established in 2002, the company maintains its headquarters in Redwood City, California.
Share Price
$1.11
Last synced: 2026-11-09
Market Cap
$121.55M
Change (1 day)
2.78%
Change (1 year)
-38.33%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Codexis, Inc. (CDXS)
Category
Healthcare
EPS for Codexis, Inc. (CDXS)
EPS as of June 2026 TTM: $-0.34
According to Codexis, Inc.'s latest financial reports, its current EPS (TTM) is $-0.34. At the end of 2025 the company had an EPS of $-0.50, an increase over its 2024 EPS of $-0.89.
EPS history for Codexis, Inc. from 2006 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.34 | -32.00% |
| 2025 | $-0.50 | -43.82% |
| 2024 | $-0.89 | -20.54% |
| 2023 | $-1.12 | 119.61% |
| 2022 | $-0.51 | 54.55% |
| 2021 | $-0.33 | -17.50% |
| 2020 | $-0.40 | 90.48% |
| 2019 | $-0.21 | 0.00% |
| 2018 | $-0.21 | -58.00% |
| 2017 | $-0.50 | 138.10% |
| 2016 | $-0.21 | 10.53% |
| 2015 | $-0.19 | -62.00% |
| 2014 | $-0.50 | -53.70% |
| 2013 | $-1.08 | 28.57% |
| 2012 | $-0.84 | 82.61% |
| 2011 | $-0.46 | 31.43% |
| 2010 | $-0.35 | -95.48% |
| 2009 | $-7.74 | -53.46% |
| 2008 | $-16.63 | 15.81% |
| 2007 | $-14.36 | 108.72% |
| 2006 | $-6.88 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -4,705.88% |
US
|
|
| $-7.07 | 1,979.41% |
US
|
|
| $-5.29 | 1,455.88% |
AU
|
|
| $12.88 | -3,888.26% |
BE
|
|
| $21.56 | -6,441.18% |
NL
|
Questions about Codexis, Inc.'s earnings per share (EPS)
What is Codexis, Inc.'s earnings per share (EPS)?
Codexis, Inc.'s earnings per share (EPS) over the last twelve months is $-0.34, as of Jun 2026.
What was Codexis, Inc.'s earnings per share (EPS) in 2025?
In 2025, Codexis, Inc.'s earnings per share (EPS) was $-0.50, compared with $-0.89 in 2024.
How has Codexis, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Codexis, Inc.'s earnings per share (EPS) was highest in 2021 ($-0.33) and lowest in 2023 ($-1.12).
How does Codexis, Inc.'s earnings per share (EPS) compare with similar companies?
Codexis, Inc.'s earnings per share (EPS) ($-0.34) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.